Patent · US Active

Hybridoma cell strain secreting nifursolol residue marker monoclonal antibody

US10882896B2 · kind B2 · utility

0Cited by
0References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 21, 2020
Grant dateJan 5, 2021
Priority date
Expiry dateJul 21, 2040

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N33/12
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

A hybridoma cell strain secreting a nifursol residue marker monoclonal antibody prepared in the following way: BALB/c mice are subjected to the first immunization with a complete Freund's adjuvant, subjected to booster immunization with an incomplete Freund's adjuvant for four times, and subjected to rush immunization once with nifursol residue marker complete antigen without a Freund's adjuvant so that the BALB/c mice are immunized; the spleen cells of the immunized mice with high titer and low IC50 were fused with mouse myeloma cells by a PEG method, and the fused cells are screened through indirect competitive ELISA and subcloned three times. The monoclonal antibody secreted by this cell strain has good specificity and detection sensitivity (IC50 value of 2 μg/L) to the nifursol residue marker and can be used for residue detection of the nifursol residual marker in food.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.